Publications
149
Citations
2,766
Est. group size
—
Recurring co-author estimate
Active years
20
Publishing since 2007
Typically publishes in teams of ~6 · 32% small-team papers (≤3 authors) · across 34 venues
- A novel transcutaneous auricular neurostimulation electrode configuration for treatment of heavy menstrual bleeding: an open-label trial
Bioelectronic Medicine · 2026
- Trends in Laboratory Evaluation and Risk Factors for Transfusion Therapy in Pediatric Epistaxis
Journal of the American College of Emergency Physicians Open · 2026
- Is oral iron cheaper? Not if you count all the costs
Blood Advances · 2026
- Past, Present, and Future of von Willebrand Disease
Advances in Therapy · 2026
- Seventh Åland Island Meeting on von Willebrand Disease
Haemophilia · 2026
- Management of iron deficiency in children, adults, and pregnant individuals: evidence-based and expert consensus recommendations
The Lancet Haematology · 2025
- Transcutaneous auricular neurostimulation to reduce heavy menstrual bleeding in women with and without von Willebrand disease
Frontiers in Medicine · 2025
- ‘Raise the Bar’, a Canadian intervention to combat disparities in the recognition and management of iron deficiency: Development of the intervention, feasibility and implementation
British Journal of Haematology · 2025
- Treatment of Bleeding Episodes With Efanesoctocog Alfa in Previously Treated Patients With Severe Hemophilia A in the Phase 3 <scp>XTEND</scp>‐1 Study
American Journal of Hematology · 2025
- HTRS2025.P1.3 Abstract of Distinction Clinical Outcomes Over 3 Years of Once-Weekly Efanesoctocog Alfa Treatment in Adults and Adolescents from North America with Severe Hemophilia A in the Phase 3 XTEND-ed Long-Term Extension Study
Research and Practice in Thrombosis and Haemostasis · 2025
- First Interim Analysis of Clinical Outcomes in Adults and Adolescents With Severe Hemophilia A Receiving Efanesoctocog Alfa Prophylaxis in XTEND-ed, a Phase 3 Long-term Extension Study
Hämostaseologie · 2025
- Management of Heavy Menstrual Bleeding in Adolescents Within the Primary Care Setting [ID 1322]
Obstetrics and Gynecology · 2025
- Women’s and Transgender Issues in Thrombosis and Hemostasis
Clinics in Laboratory Medicine · 2025
- The first characterization of disease burden and healthcare resource utilization for the recent definition of severe von Willebrand disease using a large United States real-world dataset
Blood · 2025
- A retrospective analysis of the safety and effectiveness of recombinant von willebrand factor in children with von willebrand disease undergoing surgery
Blood · 2025
- Blood×31
- Research and Practice in Thrombosis and Haemostasis×14
- Blood Advances×10
- Journal of Pediatric and Adolescent Gynecology×10
- American Journal of Hematology×9
- Sarah H. O’Brien
Medicine · The Ohio State University
- David Ginsburg
Medicine · University of Michigan
- Karl C. Desch
Medicine · University of Michigan
- Amanda Jacobson‐Kelly
Medicine · The Ohio State University
- Amy L. Dunn
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile